Beauty Farm Medical & Health Industry (FRA:XC5) Research & Development: €5.1 Mil (TTM As of Dec. 2025)


FRA:XC5 Beauty Farm Medical & Health Industry Inc FRA:XC5
86 GF Score
Price €1.67
GF Value €2.86
! 2 Warning Signs
View Full Analysis

What is Beauty Farm Medical & Health Industry Research & Development?

Beauty Farm Medical & Health Industry FRA:XC5 -3.47% 86 Research & Development is €5.1 Mil as of Dec. 2025. GuruFocus rates FRA:XC5 with a GF Score™ of 86/100 and a GF Value™ of €2.86. The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Beauty Farm Medical & Health Industry's Research & Development for the six months ended in Dec. 2025 was €2.5 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was €5.1 Mil.

Beauty Farm Medical & Health Industry  (FRA:XC5) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Beauty Farm Medical & Health Industry Research & Development Related Terms

Beauty Farm Medical & Health Industry Research & Development Historical Data

* Premium members only.

The historical data trend for Beauty Farm Medical & Health Industry's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Beauty Farm Medical & Health Industry Research & Development Chart

Beauty Farm Medical & Health Industry Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial 2.51 4.22 4.38 4.73 5.09

Beauty Farm Medical & Health Industry Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.17 2.08 2.59 2.54 2.54
FRA:XC5
86GF Score
Beauty Farm Medical & Health Industry Inc FRA:XC5
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Beauty Farm Medical & Health Industry Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €5.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €5.1 Mil mean?
Beauty Farm Medical & Health Industry (FRA:XC5) has a Research & Development of €5.1 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Beauty Farm Medical & Health Industry and its competitors.
Is Beauty Farm Medical & Health Industry's Research & Development too high?
Beauty Farm Medical & Health Industry's current Research & Development is €5.1 Mil. Overall, Beauty Farm Medical & Health Industry has a GF Score™ of 86/100, reflecting its overall financial health beyond just this single metric.
How does Beauty Farm Medical & Health Industry's Research & Development compare to HCA and THC?
Beauty Farm Medical & Health Industry's Research & Development of €5.1 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Beauty Farm Medical & Health Industry and its competitors. Beauty Farm Medical & Health Industry's current Research & Development is €5.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beauty Farm Medical & Health Industry stock overvalued right now?
Beauty Farm Medical & Health Industry (FRA:XC5) has a current Research & Development of €5.1 Mil. The stock's GF Value™ is €2.86, compared to a current price of €1.67 — trading 41.6% below its estimated fair value. The current Research & Development is €5.1 Mil. Beauty Farm Medical & Health Industry's overall GF Score™ is 86/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Beauty Farm Medical & Health Industry (FRA:XC5), the current Research & Development is €5.1 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Beauty Farm Medical & Health Industry (FRA:XC5) Overvalued in 2026?

Based on GuruFocus' analysis, Beauty Farm Medical & Health Industry stock appears to be undervalued. The current stock price of €1.67 is trading 41.6% below its estimated GF Value™ of €2.86.

Key valuation signals for FRA:XC5:

  • Research & Development: €5.1 Mil
  • GF Value™: €2.86 vs. price of €1.67 (41.6% below fair value)
  • GF Score™: 86/100 with 2 warning signs

No single metric tells the full story. See the FRA:XC5 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Beauty Farm Medical & Health Industry Business Description

Other Exchanges 02373:Hong Kong
Address No. 1089 Dongdaming Road, Unit 1206, 12th Floor, Hongkou District, Shanghai, CHN
Beauty Farm Medical & Health Industry Inc. provides beauty and wellness services in the People's Republic of China. It offers high-quality beauty and wellness services, aesthetic medical services, and subhealth medical services according to customers' individual needs. The company offers its products and services through brands such as Beauty Farm, Palaispa, Naturade, Cellcare, and Neology.
86GF Score

Get the complete analysis for FRA:XC5

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.67
Price
€2.86
GF Value